Development of aggressive plasma cell leukaemia under interferon-alpha therapy

Br J Haematol. 1991 Nov;79(3):523-5. doi: 10.1111/j.1365-2141.1991.tb08068.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Female
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / therapeutic use
  • Leukemia, Plasma Cell / etiology*
  • Middle Aged
  • Multiple Myeloma / complications
  • Multiple Myeloma / therapy
  • Recombinant Proteins

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins